The cancer secretome: A reservoir of biomarkers

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Xue, Hua ^a   Lu, Bingjian ^b   Lai, Maode ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER RESEARCH; CARCINOGENESIS; GENE FUNCTION; GENOME ANALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NONHUMAN; PREDICTION; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS; ANIMAL; GENOME; NEOPLASM; SECRETION;

ANIMALS; GENOME; HUMANS; NEOPLASMS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 53549091303     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-52     Document Type: Review

References (96)

1. Chen G Gharib TG Wang H Huang CC Kuick R Thomas DG Shedden KA Misek DE Taylor JM Giordano TJ et al. Protein profiles associated with survival in lung adenocarcinoma Proc Natl Acad Sci USA 2003, 100:13537-13542. 263849 14573703 10.1073/pnas.2233850100
2. Yeo TP Hruban RH Leach SD Wilentz RE Sohn TA Kern SE Iacobuzio-Donahue CA Maitra A Goggins M Canto MI et al. Pancreatic cancer Curr Probl Cancer 2002, 26:176-275. 10.1067/mcn.2002.129579 12399802
3. Yokota T Ishiyama S Saito T Teshima S Narushima Y Murata K Iwamoto K Yashima R Yamauchi H Kikuchi S Lymph node metastasis as a significant prognostic factor in gastric cancer: A multiple logistic regression analysis Scand J Gastroenterol 2004, 39:380-384. 10.1080/ 00365520310008629 15125471
4. Etzioni R Urban N Ramsey S McIntosh M Schwartz S Reid B Radich J Anderson G Hartwell L The case for early detection Nat Rev Cancer 2003, 3:243-252. 10.1038/nrc1041 12671663
5. Ludwig JA Weinstein JN Biomarkers in cancer staging, prognosis and treatment selection Nat Rev Cancer 2005, 5:845-856. 10.1038/nrc1739 16239904
6. Margreiter M Stangelberger A Valimberti E Herwig R Djavan B Biomarkers for early prostate cancer detection Minerva Urol Nefrol 2008, 60:51-60. 18427435
7. Hwa HL Kuo WH Chang LY Wang MY Tung TH Chang KJ Hsieh FJ Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models J Eval Clin Pract 2008, 14:275-280. 10.1111/ j.1365-2753.2007.00849.x 18284517
8. Lam T Nabi G Potential of urinary biomarkers in early bladder cancer diagnosis Expert Rev Anticancer Ther 2007, 7:1105-1115. 10.1586/ 14737140.7.8.1105 18028019
9. Menon U Jacobs I Screening for ovarian cancer Best Pract Res Clin Obstet Gynaecol 2002, 16:469-482. 10.1053/beog.2002.0297 12413929
10. Chatterjee SK Zetter BR Cancer biomarkers: Knowing the present and predicting the future Future Oncol 2005, 1:37-50. 10.1517/ 14796694.1.1.37 16555974
11. Liotta LA Ferrari M Petricoin E Clinical proteomics: Written in blood Nature 2003, 425:905. 10.1038/425905a 14586448
12. Anderson L Candidate-based proteomics in the search for biomarkers of cardiovascular disease J Physiol 2005, 563:23-60. 1665562 15611012 10.1113/jphysiol.2004.080473
13. Omenn GS States DJ Adamski M Blackwell TW Menon R Hermjakob H Apweiler R Haab BB Simpson RJ Eddes JS et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database Proteomics 2005, 5:3226-3245. 10.1002/pmic.200500358 16104056
14. Ahmed N Barker G Oliva K Garfin D Talmadge K Georgiou H Quinn M Rice G An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum Proteomics 2003, 3:1980-1987. 10.1002/pmic.200300465 14625860
15. Bjorhall K Miliotis T Davidsson P Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples Proteomics 2005, 5:307-317. 10.1002/pmic.200400900 15619298
16. Zolotarjova N Martosella J Nicol G Bailey J Boyes BE Barrett WC Differences among techniques for high-abundant protein depletion Proteomics 2005, 5:3304-3313. 10.1002/pmic.200402021 16052628
17. Fu Q Garnham CP Elliott ST Bovenkamp DE Van Eyk JE A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis Proteomics 2005, 5:2656-2664. 10.1002/pmic.200402048 15924293
18. Echan LA Tang HY Ali-Khan N Lee K Speicher DW Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma Proteomics 2005, 5:3292-3303. 10.1002/pmic.200401228 16052620
19. Yocum AK Yu K Oe T Blair IA Effect of immunoaffinity depletion of human serum during proteomic investigations J Proteome Res 2005, 4:1722-1731. 10.1021/pr0501721 16212426
20. Tjalsma H Bolhuis A Jongbloed JD Bron S van Dijl JM Signal peptide-dependent protein transport in Bacillus subtilis: A genome-based survey of the secretome Microbiol Mol Biol Rev 2000, 64:515-547. 99003 10974125 10.1128/MMBR.64.3.515-547.2000
21. Volmer MW Stuhler K Zapatka M Schoneck A Klein-Scory S Schmiegel W Meyer HE Schwarte-Waldhoff I Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer Proteomics 2005, 5:2587-2601. 10.1002/pmic.200401188 15912508
22. Welsh JB Sapinoso LM Kern SG Brown DA Liu T Bauskin AR Ward RL Hawkins NJ Quinn DI Russell PJ et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc Natl Acad Sci USA 2003, 100:3410-3415. 152306 12624183 10.1073/pnas.0530278100
23. Dombkowski AA Cukovic D Novak RF Secretome analysis of microarray data reveals extracellular events associated with proliferative potential in a cell line model of breast disease Cancer Lett 2006, 241:49-58. 10.1016/ j.canlet.2005.10.008 16298039
24. Antelmann H Tjalsma H Voigt B Ohlmeier S Bron S van Dijl JM Hecker M A proteomic view on genome-based signal peptide predictions Genome Res 2001, 11:1484-1502. 10.1101/gr.182801 11544192
25. Gronborg M Kristiansen TZ Iwahori A Chang R Reddy R Sato N Molina H Jensen ON Hruban RH Goggins MG et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol Cell Proteomics 2006, 5:157-171. 16215274
26. Khwaja FW Svoboda P Reed M Pohl J Pyrzynska B Van Meir EG Proteomic identification of the wt-p53-regulated tumor cell secretome Oncogene 2006, 25:7650-7661. 10.1038/sj.onc.1209969 17043663
27. Huang LJ Chen SX Huang Y Luo WJ Jiang HH Hu QH Zhang PF Yi H Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer Lung Cancer 2006, 54:87-94. 10.1016/j.lungcan.2006.06.011 16876904
28. Lou X Xiao T Zhao K Wang H Zheng H Lin D Lu Y Gao Y Cheng S Liu S Xu N Cathepsin D is secreted from M-BE cells: Its potential role as a biomarker of lung cancer J Proteome Res 2007, 6:1083-1092. 10.1021/ pr060422t 17284061
29. Huang LJ Chen SX Luo WJ Jiang HH Zhang PF Yi H Proteomic analysis of secreted proteins of non-small cell lung cancer Ai Zheng 2006, 25:1361-1367. 17094902
30. Zwickl H Traxler E Staettner S Parzefall W Grasl-Kraupp B Karner J Schulte-Hermann R Gerner C A novel technique to specifically analyze the secretome of cells and tissues Electrophoresis 2005, 26:2779-2785. 10.1002/elps.200410387 15966010
31. Huang CM Ananthaswamy HN Barnes S Ma Y Kawai M Elmets CA Mass spectrometric proteomics profiles of in vivo tumor secretomes: Capillary ultrafiltration sampling of regressive tumor masses Proteomics 2006, 6:6107-6116. 10.1002/pmic.200600287 17051643
32. Perera CN Spalding HS Mohammed SI Camarillo IG Identification of Proteins Secreted from Leptin Stimulated MCF-7 Breast Cancer Cells: A Dual proteomic Approach Exp Biol Med (Maywood) 2008. 18408141
33. Mlynarek AM Balys RL Su J Hier MP Black MJ Alaoui-Jamali MA A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma Arch Otolaryngol Head Neck Surg 2007, 133:910-918. 10.1001/archotol.133.9.910 17875858
34. Monteoliva L Albar JP Differential proteomics: An overview of gel and non-gel based approaches Brief Funct Genomic Proteomic 2004, 3:220-239. 10.1093/bfgp/3.3.220 15642186
35. Marouga R David S Hawkins E The development of the DIGE system: 2D fluorescence difference gel analysis technology Anal Bioanal Chem 2005, 382:669-678. 10.1007/s00216-005-3126-3 15900442
36. Lilley KS Friedman DB All about DIGE: Quantification technology for differential-display 2D-gel proteomics Expert Rev Proteomics 2004, 1:401-409. 10.1586/14789450.1.4.401 15966837
37. Liu H Lin D Yates JR 3rd Multidimensional separations for protein/ peptide analysis in the post-genomic era Biotechniques 2002, 32(4):898-902. 898, 900, 902 passim 11962611
38. Washburn MP Utilisation of proteomics datasets generated via multidimensional protein identification technology (MudPIT) Brief Funct Genomic Proteomic 2004, 3:280-286. 10.1093/bfgp/3.3.280 15642190
39. Kislinger T Gramolini AO MacLennan DH Emili A Multidimensional protein identification technology (MudPIT): Technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue J Am Soc Mass Spectrom 2005, 16:1207-1220. 10.1016/j.jasms.2005.02.015 15979338
40. Sardana G Marshall J Diamandis EP Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium Clin Chem 2007, 53:429-437. 10.1373/clinchem.2006.077370 17259234
41. Yamashita R Fujiwara Y Ikari K Hamada K Otomo A Yasuda K Noda M Kaburagi Y Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry Mol Cell Biochem 2007, 298:83-92. 10.1007/s11010-006-9354-9 17109077
42. Mbeunkui F Fodstad O Pannell LK Secretory protein enrichment and analysis: An optimized approach applied on cancer cell lines using 2D LC-MS/MS J Proteome Res 2006, 5:899-906. 10.1021/pr050375p 16602697
43. Mauri P Scarpa A Nascimbeni AC Benazzi L Parmagnani E Mafficini A Della Peruta M Bassi C Miyazaki K Sorio C Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: A strategy for identification of novel cancer markers Faseb J 2005, 19:1125-1127. 15985535
44. Washburn MP Ulaszek RR Yates JR 3rd Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology Anal Chem, 2003, 75:5054-5061. 10.1021/ ac034120b 14708778
45. Higgs RE Knierman MD Gelfanova V Butler JP Hale JE Comprehensive label-free method for the relative quantification of proteins from biological samples J Proteome Res 2005, 4:1442-1450. 10.1021/pr050109b 16083298
46. Old WM Meyer-Arendt K Aveline-Wolf L Pierce KG Mendoza A Sevinsky JR Resing KA Ahn NG Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol Cell Proteomics 2005, 4:1487-1502. 10.1074/mcp.M500084-MCP200 15979981
47. Ivakhno S Kornelyuk A Quantitative proteomics and its applications for systems biology Biochemistry (Mosc) 2006, 71:1060-1072. 10.1134/ S0006297906100026 17125453
48. Fenselau C A review of quantitative methods for proteomic studies J Chromatogr B Analyt Technol Biomed Life Sci 2007, 855:14-20. 10.1016/ j.jchromb.2006.10.071 17161666
49. Panchaud A Affolter M Moreillon P Kussmann M Experimental and computational approaches to quantitative proteomics: Status quo and outlook J Proteomics 2008, 71:19-33. 10.1016/j.jprot.2007.12.001 18541471
50. Gygi SP Rist B Gerber SA Turecek F Gelb MH Aebersold R Quantitative analysis of complex protein mixtures using isotope-coded affinity tags Nat Biotechnol 1999, 17:994-999. 10.1038/13690 10504701
51. Gygi SP Rist B Griffin TJ Eng J Aebersold R Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags J Proteome Res 2002, 1:47-54. 10.1021/ pr015509n 12643526
52. Martin DB Gifford DR Wright ME Keller A Yi E Goodlett DR Aebersold R Nelson PS Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium Cancer Res 2004, 64:347-355. 10.1158/ 0008-5472.CAN-03-2062 14729644
53. Hansen KC Schmitt-Ulms G Chalkley RJ Hirsch J Baldwin MA Burlingame AL Mass spectrometric analysis of protein mixtures at low levels using cleavable 13C-isotope-coded affinity tag and multidimensional chromatography Mol Cell Proteomics 2003, 2:299-314. 12766231
54. Yu LR Conrads TP Uo T Issaq HJ Morrison RS Veenstra TD Evaluation of the acid-cleavable isotope-coded affinity tag reagents: Application to camptothecin-treated cortical neurons J Proteome Res 2004, 3:469-477. 10.1021/pr034090t 15253428
55. Leitner A Lindner W Current chemical tagging strategies for proteome analysis by mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 2004, 813:1-26. 10.1016/j.jchromb.2004.09.057 15556511
56. Maurya P Meleady P Dowling P Clynes M Proteomic approaches for serum biomarker discovery in cancer Anticancer Res 2007, 27:1247-1255. 17593616
57. Ross PL Huang YN Marchese JN Williamson B Parker K Hattan S Khainovski N Pillai S Dey S Daniels S et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Mol Cell Proteomics 2004, 3:1154-1169. 10.1074/mcp.M400129-MCP200 15385600
58. Evans FF Raftery MJ Egan S Kjelleberg S Profiling the secretome of the marine bacterium Pseudoalteromonas tunicata using amine-specific isobaric tagging (iTRAQ) J Proteome Res 2007, 6:967-975. 10.1021/ pr060416x 17330939
59. Yang S Nan Y Tian Y Zhang W Zhou B Bu L Huo S Chen G Yu J Zheng S Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS Med Oncol 2008.
60. Wu DL Zhang WH Wang WJ Jing SB Xu YM Proteomic Evaluation of Urine from Renal Cell Carcinoma Using SELDI-TOF-MS and Tree Analysis Pattern Technol Cancer Res Treat 2008, 7:155-160. 18473487
61. Cheng L Zhou L Tao L Zhang M Cui J Li Y SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis J Cancer Res Clin Oncol 2008, 134:769-776. 10.1007/s00432-007-0344-4 18202856
62. Engwegen JY Gast MC Schellens JH Beijnen JH Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry Trends Pharmacol Sci 2006, 27:251-259. 10.1016/j.tips.2006.03.003 16600386
63. Seibert V Wiesner A Buschmann T Meuer J Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research Pathol Res Pract 2004, 200:83-94. 10.1016/j.prp.2004.01.010 15237917
64. Poon TC Opportunities and limitations of SELDI-TOF-MS in biomedical research: Practical advices Expert Rev Proteomics 2007, 4:51-65. 10.1586/ 14789450.4.1.51 17288515
65. Currid CA O'Connor DP Chang BD Gebus C Harris N Dawson KA Dunn MJ Pennington SR Roninson IB Gallagher WM Proteomic analysis of factors released from p21-overexpressing tumour cells Proteomics 2006, 6:3739-3753. 10.1002/pmic.200500787 16739131
66. Moscova M Marsh DJ Baxter RC Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines Cancer Res 2006, 66:1376-1383. 10.1158/0008-5472.CAN-05-2666 16452192
67. Hafez KS Fergany AF Novick AC Nephron sparing surgery for localized renal cell carcinoma: Impact of tumor size on patient survival, tumor recurrence and TNM staging J Urol 1999, 162:1930-1933. 10.1016/ S0022-5347(05)68071-8 10569540
68. Sarkissian G Fergelot P Lamy PJ Patard JJ Culine S Jouin P Rioux-Leclercq N Darbouret B Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis Clin Chem 2008, 54:574-581. 10.1373/clinchem.2007.090837 18202161
69. Wu CC Chien KY Tsang NM Chang KP Hao SP Tsao CH Chang YS Yu JS Cancer cell-secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model Proteomics 2005, 5:3173-3182. 10.1002/pmic.200401133 16035111
70. Weng LP Wu CC Hsu BL Chi LM Liang Y Tseng CP Hsieh LL Yu JS Secretome-Based Identification of Mac-2 Binding Protein as a Potential Oral Cancer Marker Involved in Cell Growth and Motility J Proteome Res 2008. 18646789
71. Kulasingam V Diamandis EP Proteomic analysis of conditioned media from three breast cancer cell lines: A mine for biomarkers and therapeutic targets Mol Cell Proteomics 2007. 17656355
72. Wu CC Chen HC Chen SJ Liu HP Hsieh YY Yu CJ Tang R Hsieh LL Yu JS Chang YS Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 2008, 8:316-332. 10.1002/ pmic.200700819 18203259
73. Xiao T Ying W Li L Hu Z Ma Y Jiao L Ma J Cai Y Lin D Guo S et al. An approach to studying lung cancer-related proteins in human blood Mol Cell Proteomics 2005, 4:1480-1486. 10.1074/mcp.M500055-MCP200 15970581
74. Shi Y Elmets CA Smith JW Liu YT Chen YR Huang CP Zhu W Ananthaswamy HN Gallo RL Huang CM Quantitative proteomes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: mimicking tumor microenvironment using a dermis-based cell-trapped system linked to tissue chamber Proteomics 2007, 7:4589-4600. 10.1002/ pmic.200700425 18022937
75. Roninson IB Oncogenic functions of tumour suppressor p21(Waf1/Cip1/ Sdi1): Association with cell senescence and tumour-promoting activities of stromal fibroblasts Cancer Lett 2002, 179:1-14. 10.1016/ S0304-3835(01)00847-3 11880176
76. Winters ZE Hunt NC Bradburn MJ Royds JA Turley H Harris AL Norbury CJ Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis Eur J Cancer 2001, 37:2405-2412. 10.1016/S0959-8049(01)00327-6 11720835
77. Pellitteri-Hahn MC Warren MC Didier DN Winkler EL Mirza SP Greene AS Olivier M Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells J Proteome Res 2006, 5:2861-2864. 10.1021/pr060287k 17022658
78. Marshall T Williams K Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation Electrophoresis 1996, 17:1265-1272. 10.1002/elps.1150170716 8855415
79. Pardo M Garcia A Antrobus R Blanco MJ Dwek RA Zitzmann N Biomarker discovery from uveal melanoma secretomes: Identification of gp100 and cathepsin D in patient serum J Proteome Res 2007, 6:2802-2811. 10.1021/ pr070021t 17539671
80. Volmer MW Radacz Y Hahn SA Klein-Scory S Stuhler K Zapatka M Schmiegel W Meyer HE Schwarte-Waldhoff I Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a "secretome" analysis Proteomics 2004, 4:1324-1334. 10.1002/ pmic.200300703 15188399
81. Chevallet M Diemer H Van Dorssealer A Villiers C Rabilloud T Toward a better analysis of secreted proteins: The example of the myeloid cells secretome Proteomics 2007, 7:1757-1770. 2386146 17464941 10.1002/ pmic.200601024
82. Varnum SM Covington CC Woodbury RL Petritis K Kangas LJ Abdullah MS Pounds JG Smith RD Zangar RC Proteomic characterization of nipple aspirate fluid: Identification of potential biomarkers of breast cancer Breast Cancer Res Treat 2003, 80:87-97. 10.1023/A:1024479106887 12889602
83. Celis JE Gromov P Cabezon T Moreira JM Ambartsumian N Sandelin K Rank F Gromova I Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: A novel resource for biomarker and therapeutic target discovery Mol Cell Proteomics 2004, 3:327-344. 10.1074/mcp.M400009-MCP200 14754989
84. Benowitz S Biomarker boom slowed by validation concerns J Natl Cancer Inst 2004, 96:1356-1357. 15367567
85. Kuhn E Wu J Karl J Liao H Zolg W Guild B Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards Proteomics 2004, 4:1175-1186. 10.1002/pmic.200300670 15048997
86. Desouza LV Taylor AM Li W Minkoff MS Romaschin AD Colgan TJ Siu KW Multiple Reaction Monitoring of mTRAQ-Labeled Peptides Enables Absolute Quantification of Endogenous Levels of a Potential Cancer Marker in Cancerous and Normal Endometrial Tissues J Proteome Res 2008, 7:3525-3534. 10.1021/pr800312m 18630974
87. Anderson L Hunter CL Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol Cell Proteomics 2006, 5:573-588. 16332733
88. Hanash SM Pitteri SJ Faca VM Mining the plasma proteome for cancer biomarkers Nature 2008, 452:571-579. 10.1038/nature06916 18385731
89. Hu S Loo JA Wong DT Human body fluid proteome analysis Proteomics 2006, 6:6326-6353. 10.1002/pmic.200600284 17083142
90. Chen Y Zhang H Xu A Li N Liu J Liu C Lv D Wu S Huang L Yang S et al. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer Lung Cancer 2006, 54:95-102. 10.1016/ j.lungcan.2006.06.014 16890323
91. Lin CY Tsui KH Yu CC Yeh CW Chang PL Yung BY Searching cell-secreted proteomes for potential urinary bladder tumor markers Proteomics 2006, 6:4381-4389. 10.1002/pmic.200600066 16819731
92. Kawanishi H Matsui Y Ito M Watanabe J Takahashi T Nishizawa K Nishiyama H Kamoto T Mikami Y Tanaka Y et al. Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer Clin Cancer Res 2008, 14:2579-2587. 10.1158/1078-0432.CCR-07-1922 18451219
93. Sardana G Jung K Stephan C Diamandis EP Proteomic Analysis of Conditioned Media from the PC3, LNCaP, and 22Rv1 Prostate Cancer Cell Lines: Discovery and Validation of Candidate Prostate Cancer Biomarkers J Proteome Res 2008, 7:3329-3338. 10.1021/pr8003216 18578523
94. Mbeunkui F Metge BJ Shevde LA Pannell LK Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer J Proteome Res 2007, 6:2993-3002. 10.1021/pr060629m 17608509
95. Kulasingam V Diamandis EP Proteomics analysis of conditioned media from three breast cancer cell lines: A mine for biomarkers and therapeutic targets Mol Cell Proteomics 2007, 6:1997-2011. 10.1074/ mcp.M600465-MCP200 17656355
96. Kobayashi R Deavers M Patenia R Rice-Stitt T Halbe J Gallardo S Freedman RS 14-3-3 zeta protein secreted by tumor associated monocytes/ macrophages from ascites of epithelial ovarian cancer patients Cancer Immunol Immunother 2008. 18618111